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In humans,  Chediak-Higashi  Syndrome (CHS) 1 is a  recessively inherited mu- 
tation  with  a  wide  variety  of  clinical  symptoms,  including  lowered  neutral 
proteinase activity in neutrophils (1), giant lysosomes in many tissues (2), diluted 
pigmentation  (3), prolonged bleeding time (4), decreased chemotaxis in leuko- 
cytes (5), deficiency of functional natural  killer cells (6), and increased suscepti- 
bility to infection (7). Homozygous patients are weakened by repeated infections 
and  usually  die  before  or  during  their  teen  years.  Possible  reasons  for  the 
increased  susceptibility  to  infection  include  decreased  natural  killer  cell  (6) 
activity, neutropenia,  and an inability of neutrophis  to kill invading microorga- 
nisms (8). 
The  disease  has  been  studied  by  many  investigators,  in  part  due  to  the 
availability of animal models including mutations in the mouse (9), cat (10), mink 
(1 1), killer whale (12), and cow (13). In the mouse, the recessive beige (bg) gene 
is on the proximal end of chromosome 13. Homozygous beige mice exhibit most 
of the  phenotypic  characteristics  of human  CHS  patients  (14).  An  important 
advantage in studying the mouse model is that in comparisons of beige mice to 
the normal inbred strain  on which the spontaneous mutation arose, it is highly 
probable  that  genuine  effects of the  altered  beige  gene  are  being  measured 
rather  than  unrelated  effects of differing  background  genes.  Also,  the  beige 
mutation has spontaneously arisen in several different mouse strains, so that it is 
possible to more definitively confirm any phenotypic effect of the gene. 
One of the more striking  quantitative  observations of CHS is the very large 
decrease in neutral proteinase activity of neutrophils. When [125I]-fibrin was used 
as substrate,  Vassaili et ai.  (1) found a  virtual  absence of proteinase activity in 
leukocytes of three CHS patients, and only 4-7% of normal proteinase activity 
in C57BL/6J (bgJ/bg  J) leukocytes. These authors (1) suggested, based on inhibitor 
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experiments, that the major proteinase responsible for fibrin hydrolysis in normal 
human leukocytes is elastase, and therefore that CHS patients are deficient in 
elastase. They (1) pointed out, however, that [125I]-fibrin is not hydrolyzed in 
proportion  to substrate concentration, so that enzyme levels were difficult to 
establish  precisely.  Also,  there  is  some  question  whether such  an  apparently 
nonspecific assay would measure only elastase activity, leaving open the possibility 
that other neutrophil proteinases such as coilagenase (15), plasminogen activator 
(16),  or  catbepsin  G  (17)  might  be  decreased  in  CHS. Johnson  et  al.  (18) 
confirmed that leukocytes of beige mice lack the ability to hydrolyze [~sI]-fibrin, 
but they were unable to detect elastase activity, even in normal leukocytes, using 
the more specific elastase substrate succinyl-I~-alanyl-L-alanyl-L-alanine-p-nitroan- 
ilide. This raised the additional possibility that the missing proteinase in beige 
leukocytes may not be elastase. 
In this paper, we present evidence from hydrolysis of specific substrates that 
both elastase and cathepsin G activities, which are well known neutrophil serine 
proteinases  localized  in  azurophilic  (lysosomal) granules  (19),  are  profoundly 
decreased in peritoneal neutrophils of several independent beige mouse mutants. 
In contrast, other well-established marker enzymes of lysosomal granules (14, 
19-22) are at normal or near normal levels in both normal and beige mice. 
Materials and Methods 
The following materials were obtained from the indicated sources: Ca  2+- and Mg  2+- 
free  HBSS (Gibco Laboratories,  Grand  Island,  NY); FicolI-Paque (Pharmacia  Fine 
Chemicals,  Uppsala,  Sweden);  methoxysuccinyl-alanyl-alanyl-prolyl-valine-4-methyl- 
coumarinyl-7-amide  (MeO-Suc-Ala-Ala-Pro-VaI-MCA),  t -Boc-valyl-glycyl-arginine-4- 
methylcoumarinyl-7-amide (t-Boc-Val-Gly-Arg-MCA),  and aminomethyl  coumarin (AMC) 
were  purchased  from  Vega  Biochemicals, Tucson,  AZ;  Z-glycyl-leucyl-phenylalanine 
chloromethyl  ketone (Z-GIy-Leu-Phe-CH2CI),  and methoxysuccinyl-alanyl-alanyl-prolyl- 
valine  chloromethyl  ketone  (MeO-Suc-Ala-Ala-Pro-Val-CH2Cl) from  Enzyme  Systems 
Products, Livermore,  CA; succinyl-alanyl-alanyl-prolyl-phenylalanine  p-nitroanilide  (Suc- 
Ala-Ala-Pro-Phe-pNA), succinyl-glycyl-prolyl-leucyl-glycyl-proline  4-methylcoumarinyl-7- 
amide  (Suc-Giy-Pro-Leu-Gly-Pro-MCA),  PMSF,  N-ethylmaleimide,  DMSO,  p- 
chloromercuribenzoate,  and 0-dianisidine-2HCl from Sigma Chemical Co., St. Louis, MO; 
1,3-[3H]diisopropylfluorophosphate (D1FP) (sp act,  5.2  mCi/mmol) from New England 
Nuclear,  Boston,  MA.  All  other  materials  were  of the  highest  grade  commercially 
available. 
Animals.  The C57BL/6J (+/+), C57BL/6J beige (bg°/bgJ), C3H/HeJ (+/+), C3H/HeJ 
beige (bg2J/bg2J), DBA/2J (+/+), DBA/2J beige (bgSJ/bgSJ), SB/Le (+/+), and SB/Le beige 
(bg/bg) male and female mice were originally purchased  from the Jackson  Laboratories 
(Bar Harbor, ME) and were later bred at the animal facilities of Roswell Park Memorial 
Institute. The beige mutations in the C57BL/6J, C3H/HeJ, and DBA/2J arose independ- 
ently  and spontaneously in the respective inbred lines in which they have been subsequently 
maintained.  Thus, any abnormality  in beige mutants compared to control  strain  mice 
likely is due to the beige gene. The independent mutation in the SB/Le inbred line was 
probably radiation induced (14). All mutations affect the same gene. Mice 3-10 mo old 
were used throughout the experiments. 
Bone Marrow Transplantation.  Before transplantation,  hosts received 950 rad whole 
body 6°Co irradiation.  Donor marrow was obtained  from the long bones of 6-8 wk-old 
mice. ! 07 bone marrow cells from donor femoral marrow were transplanted  via tail vein 
in a volume of 0.5 ml RPMI  1640 medium (Gibco Laboratories).  Mice were routinely 
maintained on acid water to reduce infection. Assays were performed 100 d after bone 
marrow transplantation.  Congenic mice that had electrophoretically altered forms of/3- TAKEUCHI  ET  AL.  667 
glucuronidase were used (23) as controls. Assay of fl-glucuronidase phenotypes in bone 
marrow cells of recipient mice at 100 d confirmed that the transplants were successful. 
Induction and Purification of Peritoneal Neutrophils.  Peritoneal  neutrophils  were  in- 
duced by the copper wire implantation technique developed by McGarry (24). After 24 h 
of copper wire  implantation,  cells were  recovered by peritoneal  lavage after injecting 
Ca  ~+- and  Mg~+-free HBSS  containing  5  mM  EDTA  into  the  peritgneal  cavity. The 
peritoneal exudate ceils were harvested by centrifugation and resuspension of cells was 
according to the method of Czuprynski et al. (25).  The cell suspensions were underlaid 
with Ficoll-Paque and centrifuged at 400 g for 30 min. The neutrophils were recovered 
in  a  pellet and  washed  three  times  with  HBSS/5  mM  EDTA at  20°C.  We  routinely 
obtained ~10 ~ cells per mouse; 80-95%  neutrophils.  The cells were then resuspended 
with cold 0.2% Triton X-100, 0.2 M sucrose, 5 mM EDTA in 20 mM imidazole-HCl, pH 
7.3  (homogenization  buffer),  and  homogenized  (on  ice)  with  a  sonicator  (Ultrasonic 
Processor, W-220; Heat-Systems-Ultrasonic, Inc., Farmingdale, NY) at setting 2.5, twice 
for 5  s  with a  60-s interval  between  each  burst.  The homogenate was centrifuged at 
13,000 g for 10 rain at 4°C, and the supernatant was used as a neutrophil elastase source 
or stored at -80°C until used. 
Enzyme Assays.  Elastase activity was measured  with  the  fluorogenic substrate meth- 
oxysuccinyI-Ala-Ala-Pro-Val-4-methylcoumarinyl-7-amide (MeO-Suc-AIa-AIa-Pro-Val- 
MCA) by the method of Barrett (26), modified as follows.  The regular reaction mixture 
contained,  in a final volume of 100 ttl,  40 mM Tris-HCl, pH 7.5,  8% (vol/vol) DMSO, 
0.4 M NaCI, and 0.8 mM substrate. The assay was stopped by the addition of 1 ml of 5 
M formic acid (pH 3.0).  Fluorescence product, AMC, was measured by its fluorescence 
intensity at 460 nm with excitation at 370 nm on an Aminco Fluoro-colorimeter (American 
Instrument Co., Silver Spring, MD).  1 U of activity corresponds to release of 1 umol of 
product per minute at 37 ° C. Cathepsin G was assayed using Suc-Ala-Ala-Pro-Phe-pNA as 
substrate according to the method developed by Barrett (17),  and collagenase-like pepti- 
dase (CL-peptidase) activity was measured using Suc-Gly-Pro-Leu-Gly-Pro-MCA as sub- 
strate by the method developed by Kojima et al. (27).  Plasminoget~ activator was assayed 
with t-Boc-VaI-Gly-Arg-MCA  by the modification of Nieuwenhuizen et al. (25). 
3-glucuronidase and 3-galactosidase were assayed according to the method of Brandt 
et al. (29). Myeloperoxidase was assayed according to the methods of Maelhly and Chance 
(30), with O-dianisidine as the dye. Cathepsin D was determined by the method of Ishikawa 
and Cimasoni (3 I). 
Protein was determined using the Bio-Rad protein assay (Bio-Rad Laboratories, Rich- 
mond, VA), with ovalbumin as a standard protein. 
Inhibition Studies.  PMSF and N-ethylmaleimide were dissolved in DMSO. p-Chioro- 
mercuribenzoate was made up as a stock solution in ethanol.  MeO-Suc-AIa-AIa-Pro-Vai- 
CH~CI and Z-Glu-Leu-Phe-CH2CI (32) were dissolved in methanol. 
The protein extracts were preincubated with inhibitors for 30 rain at 25°C before the 
addition of fluorogenic substrates. The preincubated mixtures were assayed for elastase 
or cathepsin G as described above. 
Gel Electrophoresis.  SDS-PAGE (12.5%  polyacrylamide gel) was performed in  115  x 
140  x  1.5  mm slabs using the  method  of Laemmli (33).  The sample buffer (pH 6.8) 
contained  50  mM  Tris-HCl,  2%  SDS,  10%  glycerol, 5  mM  EDTA,  and  0.1  M  DTT. 
Bromophenol blue at a final concentration of ~0.002%  was added to most samples just 
before electrophoresis, but was not present during the heat treatment. After electropho- 
resis, gels were stained for protein with Coomassie Brilliant Blue. 
[~H]DIFP Labeling of Peritoneal Neutrophil Extract.  Each  protein  extract  was  incu- 
bated  with  2  #Ci  of  1,3-[aH]-DIFP in  a  total  volume of 35  ttl  at  25°C  for  1  h,  and 
processed for SDS-PAGE as described above. Partially purified intact neutrophiis (1-2 X 
107 neutrophils) from normal and beige mice in HBSS/EDTA were also incubated with 
10 #Ci  [3H]-DIFP in a  total  volume of 0.5  ml at 25°C  for 2  h.  The neutrophils were 
extracted as described above, and labeled proteins were subsequently analyzed by SDS- 
PAGE. After electrophoresis and staining for protein, fluorography was done according 
to the method developed by Bonnet and Laskey (34). Enhanced gels were wrapped with 668  DEFICIENCY OF  LYSOSOMAL ELASTASE AND CATHEPSIN G 
TABLS  I 
Activities of Elastase and Cathepsin G in Neutrophil Extracts of 
Normal Mice and Four Independent Beige Mutants, and Light Ear 
and Pallid Mutants 
Strain 
Activity (U/PMN ×  106) (n) 
Elastase  Cathepsin G 
C57BL/6J (+/+)  4.26 ±  0.58  (9)  4.13 ±  0.39 (6) 
C57BL/6J (bg°/bg J)  0.11 :t: 0.05  (6)*  0.29 ±  0.04 (4)* 
C3H/HeJ (+/+)  4.8 ±  0.7  (3)  5.35 ±  0.55 (2) 
C3H/HeJ (bg2J/bg 2J)  0.04 ±  0.01  (4)*  0.20 ±  0.04 (2)* 
DBA/2J (+/+)  4.0 ±  0.7  (4)  4.95 ±  1.35 (2) 
DBA/2J (bgSJ/bg 8j)  0.1  ±  0.03  (3)*  0.56 ±  0.03 (3)  ° 
SB/Le (+/+)  3.9±0.8  (3)  3.92±1.10(2) 
SB/Le (bg/bg)  0.09 ±  0.01  (4)*  0.16 ±  0.02 (4)* 
C57BL/6J (le/le) (light ear)  4.30 ±  0.63  (4)  4.06 ±  0.42 (4) 
C57BL/6J (pa/pa) (pallid)  4.53 +_ 0.14 (4)  3.29 _ 0.09 (3) 
Peritoneal neutrophils were isolated by Ficoll-Paque centrifugation as 
described  in  Materials  and  Methods.  Elastase  was  assayed  with  the 
substrate  MeO-Suc-AIa-AIa-Pro-VaI-MCA and  cathepsin  G  with  Suc- 
Ala-Ala-Pro-Phe-pNA. 1 U of elastase activity corresponds to release of 
1  #tool  of product  per  minute.  Cathepsin  G  activity is  expressed  as 
AE/min at 410 nm (× 10s). Specific activities are expressed as means ± 
SEM  of assays  of number  of individual  mice (n)  in  parentheses.  No 
statistical difference for enzyme activity was  found between male and 
female mice of the same strain. 
* p _< 0.001. 
p <_ 0.02. 
§p _< 0.05. 
Saran-Wrap  with or without drying, and exposed to x-ray film (X-Omat  AR, Eastman 
Kodak, Rochester, NY) at -80 °C using Dupont Cronex Xtra Life intensifying screens (E. 
I.  DuPont  de  Nemours Co.,  Wilmington,  DE). The  labeled  protein  components of 
corresponding bands in the gels were extracted, and radioactivity was measured by liquid 
scintillation counting (Beckman Model LS 7500) according to the method developed by 
Basch (35). 
Results 
Reduced  Elastase  and  Cathepsin  G  Activities  in  Neutrophil  Extracts  of Beige 
Mice.  Neutrophil elastase, assayed with the specific substrate MeO-Suc-Ala-Ala- 
Pro-VaI-MCA, is drastically and uniformly reduced in four independent beige 
mutants in inbred strains C57BL/6J,  C3H/HeJ, DBA/2J, and SB/Le (Table I). 
Elastase specific activity in normal neutrophiis is 40-120 times that of neutrophils 
of the various beige mutants. Similarly, cathepsin G, assayed with Suc-Ala-Ala- 
Pro-Phe-pNA, is 9-26 times higher in normal neutrophils. 
In contrast,  normal neutrophil elastase  levels are present in the genetically 
independent coat color  mutant  mice,  pallid  and  light  ear,  which,  like  beige, 
exhibit lysosomal enzyme secretion deficiency (14) and storage pool deficiency 
(36),  but which have not been reported to have the increased susceptibility to 
infection reported in the beige mutation. 
The lysosomal serine proteinases, elastase and cathepsin G, were also examined 
in thioglycollate-induced macrophages (37), platelets from whole blood (4), and 150 
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FIGURE 1.  Protein dependency of elastase activity in normal and beige extracts. Normal 
neutrophil extracts (97% PMN in total cell preparation) and beige neutrophil extracts (94% 
PMN in total cell preparation) from strain C57BL/6J were assayed for elastase with the 
fluorogenic substrate MeO-Suc-AIa-AIa-Val-MCA. 
lymphocytes from blood (38) in normal  and beige mice. The elastase activities 
from  these  sources,  assayed  with  the  fluorogenic  substrate  MeO-Suc-Ala-Ala- 
Pro-VaI-MCA and  expressed as a  percentage  of the specific activity in  normal 
neutrophils, were very low, as follows: 0.03% in macrophages,  0.3% in lympho- 
cytes, and  0.001%  in  platelets.  Normal  and  beige extracts  from  these sources 
had the same level of activity. No significant cathepsin G activity was detected in 
any of the above preparations with Suc-Ala-Ala-Pro-Phe-pNA as substrate. 
Several tests were performed to partially characterize  the activity of the two 
proteinases in  mouse neutrophils.  The activities of both proteinases were pro- 
portional  to  time  (up  to  180  rain,  data  not  shown)  and  to  30-40  #g protein 
concentration  in  normal  neutrophils  (Fig.  1).  When  neutrophil  extracts  were 
pretreated with a series of typical proteinase inhibitors (Table II), elastase activity 
was completely inhibited by SDS.  More importantly,  the two serine proteinase 
inhibitors,  PMSF and  soybean trypsin  inhibitor,  were also effective inhibitors. 
-48% of elastase was inactivated in the presence of 1 mM PMSF and 74% was 
inactivated  at  a  concentration  of 0.1  mg/ml  soybean  trypsin  inhibitor.  The 
inhibitory effect of DTT  was also potent, with  24 and  52% of elastase activity 
being inactivated in the presence of 1 and  10 mM DTT, respectively. However, 
full activity was present  with such reagents as N-ethylmaleimide, p-chloromer- 
curibenzoate, and EDTA. These results suggest the absence of any thiol group(s) 
in the active site, and no metal ion requirement for activity. 
Since  elastase  and  cathepsin  G  were  decreased  to  similar  extents  in  beige 
neutrophil extracts, it was necessary to test that the two synthetic substrates were 
indeed measuring independent activities. For this purpose, we used the peptide 
chloromethyl  ketones including  MeO-Suc-AIa-AIa-Pro-VaI-CH2CI,  reported  to 
be  a  specific  inhibitor  of elastase  (32),  and  Z-GIy-Leu-Phe-CH2CI,  a  specific 
inhibitor  of cathepsin  G  (32).  Elastase activity (Table III) of normal and beige 
extracts was completely inhibited in the presence of 0.2 mM MeO-Suc-Ala-Ala- 
Pro-VaI-CH2CI but only slightly (-20%) in the presence of 0.2 mM Z-Gly-Leu- 670  DEFICIENCY  OF  LYSOSOMAL  ELASTASE  AND  CATHEPS1N  G 
TABLE  II 
Effects of Various Reagents on Mouse Neutrophil Elastase 
Activity re- 
Reagent  Concentration  maining (%) 
PMSF  1 mM  52.0 
N-Ethylmaleimide  1 mM  100 
p-Chloromercuribenzoate  1 mM  98.5 
Soybean trypsin inhibitor  0.1  mg/ml  26.0 
DTT  1 mM  76.0 
10 mM  48.0 
SDS  0.1%  0 
EDTA  1 mM  100 
10 mM  100 
The peritoneal neutrophils from C57BL/6J (+/+) mice were prepared as 
described in Materials and  Methods. The extracts were preincubated in 
20 mM imidazole-HCl, pH 7.2, containing 0.1  M NaCI, 0.2% Triton X- 
100,  and  0.2  M  sucrose  at  37°C  for  30  rain  with  the  reagents,  and 
remaining activity was  assayed  by standard  methods.  Each  value in  the 
table represents the percentage of activity against a  control experiment 
set at 100%. 
TABLE  III 
Inhibition with Chloromethyl Ketone Inhibitors of Elastase and Cathepsin G in Peritoneal 
Neutrophil Extracts in Normal and Beige Mice 
Enzyme  Inhibitor  Concentration  Activity remaining (%) 
(raM)  Normal  Beige 
Elastase 
Cathepsin G 
None  0  100  100 
MeO-Suc-Ala-Ala-Pro-VaI-CH~CI  2 ×  10 -~  0  0 
Z-GIy-Leu-Phe-CH2CI  2 ×  10 -l  82  81 
None  0  100  100 
Z-GIy-Leu-Phe-CH2CI  4 x  10  -s  1  0 
MeO-Suc-Ata-Ala-Pro-Val-CH2CI  4 x  10 -~  98  98 
Peritoneal  neutrophils  from C57BL/6J (+1+)  and  C57BL/6J (bgJ/bgJ) mice were prepared  as de- 
scribed in Materials and Methods. 50 ug of each extract was preincubated with 0.1  mM Z-Gly-Leu- 
Phe-CH~CI or 0.1  mM MeO-Suc-Ala-Ala-Pro-Val-CH2Cl, and this mixture was assayed for cathepsin 
G. 15 #g of each extract was preincubated with 0.5 mM Z-Gly-Leu-Phe-CH~CI or 0.5 mM MeO-Suc- 
Ala-AIa-Pro-VaI-MCA, and  this  mixture  was  assayed  for  elastase.  The  mixture  of extracts  and 
inhibitors was incubated for 30 min at 25°C in 20 mM imidazole-HC1, pH 7.3, 0.2% Triton X-100, 
and 0.2 M sucrose. Elastase and cathepsin G were assayed with MeO-Suc-Ala-Ala-Pro-Val-MCA and 
Suc-Ala-Ala-Pro-Phe-pNA, respectively, as described in Materials and Methods. The final concentra- 
tion of inhibitors is indicated in the table, and activity of enzyme is expressed as a  percentage of 
activity against a control experiment set at 100%. 
Phe-CH,~CI.  In  contrast,  0.004  mM  Z-GIy-Leu-Phe-CH2CI  nearly  completely 
inhibited  cathepsin  G  in  extracts  of  normal  and  beige  mice,  while  0.004  mM 
MeO-Suc-AIa-Ala-Pro-Val-CH2CI  caused  little  or  no  inhibition.  Therefore,  the 
elastase and  cathepsin  G  assays exhibit  nearly complete  differential  inhibition by 
the two inhibitors,  suggesting  that  the two assays are specific for their respective 
enzymes. 
Activities of  Other Enzymes.  Other  typical lysosomal enzymes, including another 
proteinase,  cathepsin  D,  the  glycohydrolases,  fl-galactosidase  and  fl-glucuroni- TAKEUCHI  ET  AL.  671 
TABLE  IV 
Enzymatic Activities of Peritoneal Neutrophils in Normal and Beige Mice 









Hemoglobin  3.32 ±  1.17  (3)  4.33 _  1.13  (3) 
Suc-Gly-Pro-Leu-Gly-Pro-MCA  0.438 +  0.030 (4)  1.220 +  0.220 (3)* 
4-methylumbellifery143-I)-galac-  3.74 4- 0.40  (5)  4.32 4- 0.36  (3) 
toside 
4-methylumbellifery143-~glucu-  7.14 ±  0.46  (4)  10.98 4- 1.04  (3) 
ronide 
H20~  2.36 +  0.26  (3)  3.13 4- 0.60  (3) 
t-Boc-Val-Gly-Arg-MCA  0.063 4- 0.005 (4)  0.103 _  0.019 (3) 
Peritoneal  neutrophils  from  C57BL/6J  (+/+)  and  C57BL/6J  (bgJ/bg a)  mice  were  prepared  as 
described  in  Materials  and  Methods.  Activities are  expressed  as  U/PMN  (x 106) _SEM,  with 
number of samples assayed (n) shown in parentheses. Cathepsin D activity is expressed as z~E/min 
at 280 nm (x 10s);  Units of activity: Collagenase-like peptidase and plasminogen activator(s) are 
expressed  as  1  #mol  of product  per  minute;  myeloperoxidase as  AE/s at  350  nm  (x 10~); /3- 
galactosidase and B-glucuronidase activities are expressed as  1 umol of product per hour (x 10s). 
Tests for significance are between noi'mal and beige mice. 
* p_< 0.05. 
dase, and myeloperoxidase were not significantly different in normal and beige 
neutrophil extracts (Table IV). Two other proteinases, plasminogen activator(s) 
and collagenase-like peptidase, whose subcellular locations have not been estab- 
lished,  were also assayed. There  was no difference in plasminogen  activator(s) 
activity in normal and beige extracts. There was, however, a relatively small (2.8- 
fold) but significant  increase  in  collagenase-like peptidase activity of beige ex- 
tracts. 
Mechanism  of Decreased  Elastase  and  Cathepsin  G Activities.  Several  indirect 
tests  were  performed  to  test  for  the  presence  of inactive  proenzyme  forms. 
Neither trypsin nor chymotrypsin treatment, however, activated elastase in beige 
extracts.  Chaotropic  reagents  such  as  NaC104  and  NaSCN  (up  to  1.5  M) or 
incubation of beige extracts at 37 °C for 10-20 h likewise produced no activation 
of elastase activity. 
We  also  tested,  by  reciprocal  bone  marrow  transplantation,  whether  the 
mechanism  of action  of the  elastase  and  cathepsin  G  deficiency involved  the 
humoral  environment  of  neutrophils,  or  was  an  intrinsic  cellular  defect  in 
neutrophils  of beige mice.  We found that  peritoneal  neutrophils  derived from 
beige mice transplanted with normal marrow retained high elastase and cathepsin 
G  levels, while these activities were barely detectable in peritoneal  neutrophils 
derived from normal mice transplanted with beige marrow (Table V). It is likely, 
therefore, that the lowered proteinase activity in beige neutrophils  is a  cellular 
defect intrinsic to bone marrow cells. 
We wished to  determine  whether  the  beige mutation  affected other  serine 
proteinases.  Incubation of extracts with labeled DIFP, which is known to cova- 
lently bind to the active site of serine proteinases, is one method of testing this 
question.  Accordingly,  extracts  were  labeled  with  [~H]DIFP  and  individual 
labeled proteins were detected and compared in normal and beige extracts after 
SDS-PAGE and exposure to x-ray film.  There was no difference in the fluoro- 672  DEFICIENCY  OF  LYSOSOMAL  ELASTASE  AND  CATHEPSIN  G 
TABLE  V 
Reciprocal Bone Marrow Transplantation  Between Beige 
and Normal Mice 
Donor  Recipient  Mouse 
Activity (U/PMN x  10 6) 
Cathepsin G  Elastase 
+/+  bgO  /bg  I  1  2.89  2.87 
2  3.39  5.79 
bgJ/bgJ  +/+  1  O. 11  0 
2  0.14  0,14 
Bone marrow was transplanted between C57BL/6J (+/+) and C57BL/6J 
(bga/bg  3) as described  in  Materials and  Methods.  Peritoneal  neutrophils 
were prepared from C57BL/6J (+/+) and C57BL/6J (bga/bg'l), as described 
in Materials and Methods. Cathepsin G and elastase activities were assayed 
from  each  preparation  by  the  standard  procedure,  with  the  substrate 
MeO-Suc-Ala-AIa-Pro-VaI-MCA for  elastase  and  Suc-Ala-Ala-Pro-Phe- 
pNA for cathepsin G. 
graphic patterns of labeled protein, whether [~H]DIFP was added before or after 
homogenization of neutrophils of normal and beige mice. In agreement with the 
elastase  and  cathepsin  G  assay  results,  beige  neutrophil  extract  is  markedly 
deficient in one major and two minor [3H]DIFP-iabeled bands (2,500 vs. 30,300 
cpm total  in  the  three bands  in  normal extracts) at Mr  25,000,  27,000,  and 
30,000  (Fig.  2).  This result is in agreement with the deficiency of elastase and 
cathepsin  G  activities,  since  similar Mr  have  been  reported  for  elastase  and 
cathepsin  G  of human  neutrophils  (17,  26,  39).  In  contrast,  there  were  no 
significant differences between normal and beige mice in seven other relatively 
minor [3H]DIFP-labeled proteins at Mr 90,000-95,000,  75,000-80,000,  50,000, 
and 22,000. There were likewise no major differences in total neutrophil proteins 
of normal and beige mice, as determined by Coomassie Blue staining (Fig.  2,  b 
and c). 
Evidence that  the mechanism responsible for the deficiency in elastase and 
cathepsin G  involves processing genes rather than alterations in the structural 
genes for elastase and cathepsin G was obtained from analysis of these activities 
in Fl heterozygous mice from a cross between C57BL/6J (+/+) and C57BL/6J 
(bg~/bg~). The values of cathepsin G and elastase activities in neutrophils of F1 
mice,  rather  than  being  intermediate between  normal  and  mutant  values  as 
expected for a structural gene mutation (40), are not significantly different from 
normal levels (Table VI). 
Discussion 
These findings show that both elastase and cathepsin G, as assayed with specific 
(17, 41, 42) and sensitive synthetic substrates, are nearly completely missing in 
inflammatory neutrophils of four independent beige mouse mutants. This finding 
confirms and extends the observation of Vassalli et al. (1), who pointed out the 
leukocyte neutral proteinase deficiency in CHS patients and beige mice, using 
fibrin degradation as an assay. 
The elastase plus cathepsin G deficiency appears to be intrinsic to the cells of TAKEUCHI  ET  AL.  673 
FIGURE  2.  SDS-PAGE of [3H]DIFP-labeled protein from peritoneal neutrophils of normal 
and beige mice.  [SH]DIFP-labeled proteins from peritoneal neutrophils of normal and beige 
mice were  analyzed on  12.5%  polyacrylamide gel containing 0.1%  SDS.  (a)  [~4C]-labeled 
standard proteins: phosphorylase B (Mr, 92,500), BSA (Mr, 68,000), ovalbumin (Mr, 45,000), 
carbonic anhydrase (Mr, 30,000),  and  lysozyme  (Mr, 14,300),  respectively. Lanes b and  d, 
peritoneal neutrophil extract from normal mice (1.3 × 106 neutrophils); lanes c and e, peritoneal 
neutrophil extract from beige mice (1.3 x  106 neutrophils). Lanes b and c were stained for 
protein with Coomassie Brilliant Blue. After staining for protein and enhancing, the gels (lanes 
b and c) were processed for fluorography to obtain lanes d and e. Fluorograms were obtained 
by exposure of the gel to x-ray film for 6  d.  Horizontal arrows indicate [SH]DIFP-labeled 
bands at Mr 25,000, 27,000, and 30,000, which are decreased in neutrophils of beige mice. 
TABLE  VI 
Peritoneal Neutrophil Cathepsin  G and Elastase Activity of 
Heterozygous (+  /bg  j) Mice 
Activity (U/PMN ×  10  6) (n) 
Genotype 
Cathepsin G  Elastase 
C57BL/6J (+/+)  4.13 _  0.39 (6)  4.26 + 0.58 (9) 
C57BL/6J (+/bg  J)  5.87 4- 0.41  (6)  5.31  + 0.75 (9) 
C57BL/6J (bgJ/bg  I)  0.29 4- 0.04 (4)*  0.11  + 0.05 (6)* 
Elastase was assayed with the substrate MeO-Suc-Ala-Ala-Pro-Val-MCA 
and cathepsin G with Suc-Ala-Ala-Pro-Phe-pNA.  Activities  are expressed 
as  mean  4-SEM of assays  of the  number  of individual mice  (n)  in 
parentheses. 
* p  _< 0.001. 
beige mice rather than humoral, since bone marrow  transplantation from normal 
to  beige corrected  the  proteinase  deficiency.  This  general conclusion  confirms 
studies  of  other  properties  of  the  beige  mutation  (reviewed  in  14)  that  the 
primary  CHS  defect  is a  true  cellular defect  rather  than  an  altered  diffusible 
regulatory  product.  Also,  recent  studies  have  successfully  corrected  several 
characteristics  of  CHS  by  transplantation  of normal  marrow  into  an  affected 674  DEFICIENCY  OF  LYSOSOMAL  ELASTASE  AND  CATHEPSIN  G 
patient (43) and into beige mice (23,  44).  It remains possible that a  diffusible 
factor produced by other bone marrow derived cells could explain these results. 
The deficiency of elastase and cathepsin G  in beige neutrophils is specific in 
that other lysosomal enzymes including ~-glucuronidase, ~3-galactosidase,  myelo- 
peroxidase, and cathepsin D remain at normal levels. We have likewise shown in 
previous studies (29) that B-glucuronidase,/3-galactosidase, and hexosaminadase 
are found at normal  levels in  six  organs of beige mice. The normal levels of 
cathepsin D indicate that there is not a general proteinase deficiency. Also, there 
is not a general deficiency of serine proteinases, as determined by the fact that 
[3H]DIFP bound at normal levels to a large number of serine proteinases at Mr 
different from  that  of elastase  and  cathepsin  G.  Likewise,  major  neutrophil 
protein components, separated by one-dimensional gel electrophoresis, are iden- 
tical in normal and beige mice. 
As  Vassalli  et  al.  (1)  pointed  out,  a  decrease in  elastase  activity  could be 
responsible for the increased susceptibility to infection that is characteristic of 
this disease. The peptidoglycan structure of an organism such as Staphylococcus 
aureus, to which CHS patients are specifically susceptible (45) contains an elastase- 
sensitive bond. Our results show that the proteinase deficiency in this disease is 
more severe than simply a loss of elastase activity. It is possible that the additional 
deficiency of cathepsin G may exacerbate the inability to kill invading microor- 
ganisms associated with the elastase deficiency. In other systems, Boudiere et al. 
(46) found that the elastolytic activity was stimulated five to six times higher than 
that of elastase alone or cathepsin G alone when a mixture of both enzymes was 
used. A more modest 1.1-2.9-fold synergism of elastolysis was reported by Reilly 
et al. (47). 
Our results also show that the deficiency of elastase and catepsin G is unlikely 
to be the primary genetic defect in CHS. First, two enzymes (rather than one as 
would be expected for a primary defect) are affected. Second, Fj heterozygous 
mice do not show intermediate levels of either enzyme, as would be expected for 
a mutation in the primary structure of the enzyme (40). 
Summary 
A  profound  decrease in  activities  of the  two  lysosomal  serine  proteinases, 
elastase, and cathepsin G, was found in neutrophils of four independent beige 
mutants.  Elastase  and  cathepsin  G  activities  were  assayed  with  the  specific 
synthetic substrates  MeO-Suc-Ala-Ala-Pro-Val-MCA and Suc-Ala-Ala-Pro-Phe- 
pNA, respectively. The defect is intrinsic to cells of beige mice, since transplan- 
tation of bone marrow from normal to mutant mice restored normal proteinase 
activity, and normal mice transplanted with beige marrow produced neutrophils 
with a  deficiency of proteinase activity. The  loss  of elastase and cathepsin G 
activity was confirmed by separation of [3H]diisopropylfluorophosphate-labeled 
proteins on denaturing gels, which also revealed that other serine proteinases 
are at normal levels in  beige neutrophil extracts. The deficiency of lysosomal 
proteinase activity appears specific, in that four other common neutrophil lyso- 
somal enzymes, plus the spectrum of major neutrophil proteins are not affected 
by the beige  mutation.  The deficiency of proteinase activity is  likely not  the 
primary genetic alteration of the beige mutation, since more than one proteinase TAKEUCHI  ET AL.  675 
is  affected,  and  heterozygous  F,  mice  have  normal  rather  than  intermediate 
levels of both proteinases. The lowered proteinase activity may contribute to the 
high susceptibility of beige mice and Chediak-Higashi patients to infection. 
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